Socialguy, what I would like to know is what happened in the US around 10.45 am yesterday?
Someone in the know over there I believe?
Novogen Limited (NVGN)
-NasdaqCM
2.79 0.25(9.84%) 06:00
Add to Portfolio
Prev Close: 2.54 1 Open: 2.55 2 Bid: 2.82 x 100 3 Ask: 3.75 x 2000 4 1y Target Est: 3.51 5 Beta: -1.0746 6 Next Earnings Date: N/A
Day's Range: 2.51 - 2.79 1 52wk Range: 1.51 - 9.50 2 Volume: 127,259 3 Avg Vol (3m): 179,006 4 Market Cap: 47.22M 5 P/E (ttm): N/A 6 EPS (ttm): -0.53 7 Div & Yield: N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
» More Headlines for NVGN
- Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
- Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
- Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
- H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
- Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
- Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
- Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)
Press Releases
» More Press Releases for NVGN
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
Prev Close: 2.54 1 Open: 2.55 2 Bid: 2.82 x 100 3 Ask: 3.75 x 2000 4 1y Target Est: 3.51 5 Beta: -1.0746 6 Next Earnings Date: N/A
Day's Range: 2.51 - 2.79 1 52wk Range: 1.51 - 9.50 2 Volume: 127,259 3 Avg Vol (3m): 179,006 4 Market Cap: 47.22M 5 P/E (ttm): N/A 6 EPS (ttm): -0.53 7 Div & Yield: N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Novogen (NVGN) Conducts Scientific Review of R&D ProgramZacks(Tue 1 Sep)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
- Anisina Receives Orphan Drug Designation from FDA for NeuroblastomaPR Newswire(Thu 16 Jul)
- Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood CancerPR Newswire(Tue 14 Jul)
- H.C. Wainwright: Time To Buy NovogenBenzinga(Wed 1 Jul)
- Coverage initiated on Novogen by H.C. WainwrightBriefing.com(Wed 1 Jul)
- Novogen Announces the Chairman's Address at the Company's General MeetingPR Newswire(Wed 24 Jun)
- Anisina on Track to Enter Clinic in 2016PR Newswire(Wed 24 Jun)
- Novogen Announces The Outcome Of A Comprehensive Science ReviewPR Newswire(Mon 31 Aug)
- Newly Appointed Acting CEO Outlines Immediate Plans for NovogenPR Newswire(Thu 30 Jul)
- Novogen Appoints Iain Ross as Acting CEO and Re-appoints Him to the BoardPR Newswire(Wed 22 Jul)
» More Press Releases for NVGN
Check out the large Spike in Volume around 10.45AM in the US Yesterday.
Column 1 1
There has to be some news coming IMHO>
- Forums
- ASX - By Stock
- Major breakout of NVGN on NASDAQ
Socialguy, what I would like to know is what happened in the US...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online